Loading
Distinct shells carrying a filed role for this person — not every shell they have ever touched.
Of those vehicles, the ones that closed a merger.
Announced but not closed, and still hunting.
No closed vehicle here has both a stored price and a filed trust value to score it against.
1 vehicle on file, newest listing first
none appears on more than one
Joel David Mayersohn is an independent director who has been a member at Dickinson Wright PLLC since June 2017, specializing in corporate, securities and business law, advising clients on private placements, public offerings, mergers and acquisitions, financing transactions, and general securities law matters. He also has experience in venture capital, bridge loans, and PIPE financings. He served as a director of TenX Kean Acquisition from its initial public offering in October 2022 until it consummated its initial business combination with Citius Pharmaceuticals, Inc. in August 2024.
This record is keyed to SEC CIK 0001588395 — the identifier this person files under in their own name. Every vehicle above is a filing made under that CIK, so “the same person on two shells” is a fact about an SEC identifier rather than about a name that happens to match.
Roles are the strings the filings used, in the order they were filed. Nothing on this page ranks them, infers seniority, or offers a reason why any two of these names recur — a recurrence is a count, and the filings that produced it are linked beside every row. We also hold 9 institutional-holder rows on these vehicles, under 8 distinct name strings, and none of them is counted across vehicles: that table has no CIK column, and matching holders by name would merge firms that are not the same firm.